NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Alibaba
BABA
US Stock MarketDetailed Quotes
FMS Fresenius Medical Care
- 23.510
- +0.060+0.26%
Trading Feb 26 10:28 ET
13.80BMarket Cap24.44P/E (TTM)
23.520High23.423Low53.11KVolume23.480Open23.450Pre Close1.25MTurnover0.01%Turnover Ratio24.44P/E (Static)586.83MShares25.25052wk High0.90P/B9.35BFloat Cap17.79452wk Low0.62Dividend TTM397.85MShs Float51.648Historical High2.62%Div YieldTTM0.42%Amplitude0.515Historical Low23.481Avg Price1Lot Size
Fresenius Medical Care Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.23%2.39B | -56.11%442M | -10.87%127.31M | 21.29%2.63B | 34.09%1.01B | -10.00%142.84M | ||||
| Net income from continuing operations | 1.15%740.87M | -53.65%118.87M | 79.59%264M | 23.59%241M | -11.61%118.32M | -18.10%732.46M | 32.48%256.46M | -48.04%147M | -5.34%195M | -36.80%133.85M |
| Operating gains losses | -9.17%-147.04M | ---- | ---- | ---- | 24.72%-40.21M | 18.78%-134.69M | ---- | ---- | ---- | -278.21%-53.41M |
| Depreciation and amortization | -0.55%1.74B | ---- | ---- | -10.83%387M | 17.05%512.44M | -4.70%1.75B | ---- | ---- | 2.84%434M | 4.50%437.81M |
| Deferred tax | 40.51%-72.67M | ---- | ---- | ---- | -98.30%-44.37M | -194.54%-122.15M | ---- | ---- | ---- | -140.70%-22.37M |
| Other non cash items | -0.28%335.47M | 45.65%-596.53M | ---- | ---- | 6.80%88.19M | 15.03%336.42M | -1,557.32%-1.1B | 701.46%613M | ---- | 19.50%82.57M |
| Change In working capital | -20.84%444.31M | ---- | ---- | -149.21%-186M | -24.63%-420.83M | 538.27%561.28M | ---- | ---- | 207.32%378M | 17.18%-337.67M |
| -Change in receivables | 51.61%-73.48M | 1,082.15%155.52M | 644.71%463M | -107.06%-23M | -54.89%-552.72M | -225.27%-151.84M | 449.89%13.16M | -324.26%-85M | 84.18%326M | -42.46%-356.85M |
| -Change in inventory | 921.13%107.9M | 123.74%95.9M | 23.64%68M | 31.82%-15M | 53.62%-41M | 93.57%-13.14M | 221.65%42.86M | 208.42%55M | 60.71%-22M | -42.44%-88.39M |
| -Change in payables and accrued expense | 9.87%637.86M | ---- | ---- | ---- | 64.90%190.81M | 1,966.22%580.56M | ---- | ---- | ---- | 175.63%115.72M |
| -Change in other current assets | -256.47%-227.97M | ---- | ---- | ---- | -120.04%-17.93M | -5.41%145.7M | ---- | ---- | ---- | -114.08%-8.15M |
| -Change in other working capital | ---- | ---- | ---- | -300.00%-148M | ---- | ---- | ---- | ---- | 3,600.00%74M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.23%2.39B | 15.77%832.14M | 29.47%984M | -56.11%442M | -10.87%127.31M | 21.29%2.63B | 19.87%718.8M | 15.57%760M | 34.09%1.01B | -10.00%142.84M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 84.39%-84.94M | 1.29%-306M | 58.13%-68.37M | 25.93%-544.23M | 8.28%-310M | 22.73%-163.28M | ||||
| Capital expenditure reported | ---- | ---- | -26.12%-169M | 1.29%-153M | ---- | ---- | ---- | ---134M | 8.28%-155M | ---- |
| Net PPE purchase and sale | -2.51%-685.26M | ---- | ---- | 1.29%-153M | 7.83%-129.49M | 2.81%-668.46M | ---- | ---- | 8.28%-155M | 12.11%-140.49M |
| Net business purchase and sale | 342.84%606.68M | ---- | ---- | ---- | 402.71%40.58M | 13,226.75%137M | ---- | ---- | ---- | 136.25%8.07M |
| Net investment purchase and sale | 50.13%-6.37M | ---- | ---- | ---- | 166.59%20.55M | 73.38%-12.77M | ---- | ---- | ---- | -5.69%-30.86M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 84.39%-84.94M | ---- | ---- | 1.29%-306M | 58.13%-68.37M | 25.93%-544.23M | ---- | ---- | 8.28%-310M | 22.73%-163.28M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -38.24%-2.57B | -14,482.17%-289.66M | -14.91%-1.86B | 100.76%2.01M | ||||||
| Net issuance payments of debt | -60.12%-1.91B | ---- | ---- | ---- | -245.43%-514.14M | -6.42%-1.19B | ---- | ---- | ---- | 79.66%-148.84M |
| Cash dividends paid | -6.25%-349.16M | ---- | ---- | ---- | ---- | 16.92%-328.62M | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | 7.39%-314.99M | ---- | ---- | ---- | 48.81%224.48M | -174.40%-340.11M | ---- | ---- | ---- | -67.50%150.85M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -38.24%-2.57B | ---- | ---- | ---- | -14,482.17%-289.66M | -14.91%-1.86B | ---- | ---- | ---- | 100.76%2.01M |
| Net cash flow | ||||||||||
| Beginning cash position | 12.05%1.43B | ---- | ---- | ---- | 12.05%1.43B | -14.03%1.27B | ---- | ---- | ---- | -14.03%1.27B |
| Current changes in cash | -218.60%-268.1M | ---- | ---- | ---- | -1,151.99%-230.72M | 222.38%226.05M | ---- | ---- | ---- | 94.23%-18.43M |
| Effect of exchange rate changes | 136.08%26.2M | ---- | ---- | ---- | 85.66%-4.51M | -213.47%-72.61M | ---- | ---- | ---- | -387.47%-31.47M |
| End cash Position | -16.95%1.19B | ---- | ---- | ---- | -2.61%1.19B | 12.05%1.43B | ---- | ---- | ---- | 4.31%1.22B |
| Free cash flow | -13.24%1.69B | 16.21%1.04B | 32.72%649M | -81.35%130M | -1,036.36%-6.59M | 34.70%1.94B | 142.58%898.21M | -1.66%489M | 70.00%697M | 120.77%704K |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |